|
|
Article: After Stock Bounce, Amylin Raises $152M For Pipeline.
- Article from:
- BIOWORLD Today
- Article date:
- November 3, 2009
CopyrightCOPYRIGHT 2009 A Thomson Healthcare Company. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Staff Writer
Following a rise of more than 27 percent in its stock last week, Amylin Pharmaceuticals Inc. is selling more than 5 million shares of common stock to bring in $152 million.
Amylin offered the stock at $31 a share and had about 104 million common shares outstanding before the offering.
The financing includes shares from a shelf registration for $300 million filed in December 2003 and one for 13.3 million shares in 2001. In February, the company completed a public offering of 9.2 million shares of its common stock at $22 per share, for net proceeds of $190 million. The remaining shares from the two registrations coupled with an ...